Position in MDCX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,810
+$645 QoQ
Shares Held
17,512
+12.2% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 23 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $5,886,151,720 across 17 Drug Manufacturers - General names. MDCX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,274,807 | $1,529,041,887 | |
| 2 | JNJ |
Johnson & Johnson
|
5,055,143 | $1,283,854,667 | |
| 3 | ABBV |
AbbVie Inc.
|
4,096,323 | $1,030,798,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,836,733 | $493,020,190 | |
| 5 | AMGN |
Amgen Inc
|
1,188,164 | $430,257,947 | |
| 6 | PFE |
Pfizer Inc
|
13,919,821 | $335,189,289 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,265,381 | $188,151,253 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
969,813 | $122,526,174 |
All Filings in MDCX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,810 | 17,512 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $7,165 | 15,612 | Shares | Sole | 2026-05-06 | |
| 2025-09-30 | $43,408 | 18,751 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||